Please assess the completion status of the following clinical trial:

Trial Title: Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy individuals free of clinically relevant cardiovascular diseases or diabetes based on medical history and physical examination.~* Heart rhythm: Sinus rhythm~* Blood pressure range: 10 to 12 subjects in each of the three systolic blood pressure (SBP) and three diastolic blood pressure (DBP) recruitment ranges (low, medium, high).~Exclusion Criteria:~* Cardiac arrhythmia (atrial fibrillation, frequent extrasystoles)~* Pacemaker-dependent~* Pregnancy after the 6th month of the pregnancy~* Body mass index (BMI)\>30 kg/m2~* Known significant carotid or femoral artery stenosis~* Impalpable arterial pulse at site of measurement~* Age under 18 years.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Pulse wave analysis measurement (Type: EXPERIMENTAL): Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device

Based on this trial design, predict the completion outcome and termination type (if applicable).